Table 2

Changes in lipid level in patients with baseline LDL cholesterol ≥2.6 mmol/litre

Mean (SD)
Month 0Month 6Month 12p Value*
Total cholesterol, mmol/litre
 Raloxifene (N=35)5.77 (0.83)5.33 (0.75)5.43 (0.99)0.04
 Placebo (N=29)6.09 (1.11)5.88 (0.96)6.16 (0.93)0.28
LDL cholesterol, mmol/litre
 Raloxifene (N=35)3.35 (0.69)3.00 (0.83)3.14 (0.88)0.08
 Placebo (N=29)3.68 (0.95)3.56 (0.85)3.76 (0.79)0.19
HDL cholesterol, mmol/litre
 Raloxifene (N=35)1.72 (0.46)1.60 (0.42)1.62 (0.48)0.13
 Placebo (N=29)1.65 (0.45)1.56 (0.44)1.61 (0.43)0.14
Triglyceride, mmol/litre
 Raloxifene (N=35)1.51 (0.65)1.70 (1.10)1.64 (0.99)0.59
 Placebo (N=29)1.69 (0.81)1.89 (1.10)1.75 (0.76)0.14
  • * Comparison between month 0 and 12.

  • HDL, high-density lipoprotein; LDL, low-density lipoprotein.